Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer.

CME information and select publications here.